(Total Views: 402)
Posted On: 03/31/2020 5:06:27 PM
Post# of 145906
![Avatar](https://investorshangout.com/images/ProfileImages/573000060_60093_FD245EF6-37BD-4C88-9356-29519D0376AD.jpeg)
Re: thriftycents #24370
The one question I’d like him to discuss and one which I’m sure he’s working on: manufacturing for demand.
Obviously not every COVID19 patient will need leronlimab, but any displaying shortness of breath and/or requiring hospitalization should receive the medication to prevent further complications. That is still a significant number of patients in the U.S. and around the world.
Obviously not every COVID19 patient will need leronlimab, but any displaying shortness of breath and/or requiring hospitalization should receive the medication to prevent further complications. That is still a significant number of patients in the U.S. and around the world.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)